QA: REVIVA PHARMACEUTICALS HOLDINGS INC. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001742927_2021_REVIVA_PHARMACEUTICALS_HOLDINGS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001742927')"}

Graph

Absolute values for 0001742927, REVIVA PHARMACEUTICALS HOLDINGS INC.

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 8,762,278
4 LiabilitiesCurrent 1,008,046
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,288,482
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,139,501
9 ResearchAndDevelopmentExpense 295,150
10 remainder_Expenses 800
11 remainder_Revenues 0
12 remainder_NetIncome -1,347,937
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 8,762,278
1 Liabilities 3,296,528
2 Expenses 2,435,451
3 Revenues 0
4 StockholdersEquity 5,465,750
5 NetIncome -3,783,388
6 ComprehensiveNetIncome -3,783,388
7 BaseVar 7,921,097
8 EconomicCapitalRatio 0.932

Edgar->Model Mapping

Feature Distribution

Change over Time